Benzgalantamine
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Comparison table: Drugs for Alzheimer's disease dementia.
Journal: The Medical letter on drugs and therapeutics
Published: March 24, 2026
FDA approval of benzgalantamine exposes flaws in the 505(b)(2) pathway for innovations on existing drugs.
Journal: BMJ evidence-based medicine
Published: February 01, 2026
Benzgalantamine (Zunveyl) for the Treatment of Mild to Moderate Alzheimer Disease.
Journal: American family physician
Published: July 30, 2025
Benzgalantamine (Zunveyl) for Alzheimer's disease.
Journal: The Medical letter on drugs and therapeutics
Published: April 20, 2025
Effect of Alzheimer's disease medications on neurocognitive outcomes in children and adolescents with autism spectrum disorder and low IQ: a scoping review.
Journal: Translational psychiatry
Published: November 06, 2023
Showing 1-6 of 6
Last Updated: 06/30/2026